Previous 10 | Next 10 |
DUBLIN, Ireland, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended June 30, 2022 and prel...
DUBLIN, Ireland, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2022 on Thursday, Novemb...
DUBLIN, Ireland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announces the appointment of Mr. Tom Lindsay to its Board of Directors as an indepe...
Summary We are bullish on the at-home testing healthcare market but bearish for retail value investors on Fulgent Genetics until growth and momentum improve. They reported revenue growth and profits, hold a lot of cash, but face a year of possible slowing revenue and significantly...
Trinity Biotech ( NASDAQ: TRIB ) on Monday said it had appointed Aris Kekedjian as its CEO, succeeding co-founder Ronan O’Caoimh. Kekedjian had also been named chairman of the company's board, TRIB said in a statement . According to TRIB, Kekedjian...
DUBLIN, Ireland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the appointment of Mr. Aris Kekedjian as CEO with effect from October 3, ...
DUBLIN, Ireland, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the results of an Annual General Meeting (AGM). A GM Results...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for another breakdown of the biggest pre-market stock movers and the news moving them on Wednesday! We’ve got a SPAC merger, special shareholder meetings, st...
Trinity Biotech plc (TRIB) Q1 2022 Earnings Conference Call June 30, 2022, 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Ronan O’Caoimh - Chairman and Chief Executive Officer John Gillard - Chief Financial Officer and Director Confe...
Trinity Biotech press release ( NASDAQ: TRIB ): Q1 GAAP EPADS of -50c. Revenue of $18.78M (-26.6% Y/Y) misses by $1.22M . For further details see: Trinity Biotech GAAP EPADS of -50c, revenue of $18.78M misses by $1.22M
News, Short Squeeze, Breakout and More Instantly...
DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced steps to advance its next generation continuous glucose monitoring (...
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to at...
DUBLIN, June 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the launch of its continuous glucose monitoring (“CGM”...